SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
SUPERNUS PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$39.84+1.96 (+5.17%)
Close on Oct 19, 2026
- Market cap
- $2.31B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
100.0%
60M of 58M shares
Institutional holders
333
47 new, 35 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 20 sales
Net sold $10.26M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 8,197,023 | 14.70% | 13G (passive) amendment | Mar 31, 2025 |
| Millennium Management LLC | 3,853,212 | 6.60% | 13G (passive) amendment | Jun 30, 2026 |
| Israel A. Englander | 3,281,615 | 5.70% | 13G (passive) amendment | Feb 11, 2026 |
| Vanguard Portfolio Management | 3,263,309 | 5.66% | 13G (passive) | Mar 31, 2026 |
| Millennium Group Management LLC | 3,036,123 | 5.30% | 13G (passive) | Jan 26, 2026 |
| Vanguard Capital Management | 2,900,884 | 5.03% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SUPN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 9,350,046 | 16.09% | $434.87M | +552,792 | 0.01% |
| Millennium Management LLC | 3,853,212 | 6.63% | $179.21M | +537,239 | 0.06% |
| Vanguard Portfolio Management LLC | 3,305,429 | 5.69% | $153.74M | +66,736 | 0.01% |
| Armistice Capital, LLC | 2,646,201 | 4.55% | $123.07M | +750,854 | 1.51% |
| Vanguard Capital Management LLC | 2,516,721 | 4.33% | $117.05M | +49,506 | 0.00% |
| State Street Corp | 2,459,828 | 4.23% | $114.41M | +171,701 | 0.00% |
| Nomura Asset Management International Inc. | 2,378,329 | 4.09% | $110.62M | +341,127 | 0.17% |
| Dimensional Fund Advisors LP | 2,078,090 | 3.58% | $96.65M | −228,940 | 0.02% |
| Geode Capital Management, LLC | 1,570,088 | 2.70% | $73.04M | −53,426 | 0.00% |
| Stephens Investment Management Group LLC | 1,485,821 | 2.56% | $69.11M | +134,490 | 0.74% |
| Renaissance Technologies LLC | 1,478,180 | 2.54% | $68.75M | −227,042 | 0.09% |
| Loomis Sayles & Co L P | 1,475,192 | 2.54% | $68.61M | +49,413 | 0.09% |
| Citadel Advisors LLC | 1,373,982 | 2.36% | $63.90M | −119,464 | 0.01% |
| Two Sigma Investments, LP | 1,184,378 | 2.04% | $55.09M | +913,150 | 0.04% |
| GW&K Investment Management, LLC | 1,037,242 | 1.78% | $48.24K | −17,942 | 0.38% |
| Sofinnova Investments, Inc. | 1,036,328 | 1.78% | $48.20M | +82,019 | 2.49% |
| Qube Research & Technologies Ltd | 922,166 | 1.59% | $42.89M | +423,968 | 0.04% |
| Morgan Stanley | 876,841 | 1.51% | $40.78M | −37,052 | 0.00% |
| Goldman Sachs Group Inc | 819,432 | 1.41% | $38.11M | −37,055 | 0.00% |
| D. E. Shaw & Co., Inc. | 767,668 | 1.32% | $35.70M | +145,218 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 333 | 60M | 100.0% | 47 / 119 | 112 / 35 | 8M | 5M |
| Q1 2026 | 328 | 58M | 100.0% | 42 / 117 | 118 / 41 | 13M | 6M |
| Q4 2025 | 333 | 57M | 98.3% | 63 / 113 | 113 / 33 | 9M | 10M |
| Q3 2025 | 310 | 58M | 99.6% | 61 / 93 | 117 / 43 | 7M | 9M |
| Q2 2025 | 295 | 60M | 100.0% | 38 / 122 | 86 / 34 | 4M | 4M |
| Q1 2025 | 295 | 59M | 100.0% | 37 / 112 | 96 / 33 | 4M | 5M |
| Q4 2024 | 294 | 60M | 100.0% | 42 / 101 | 99 / 20 | 3M | 3M |
| Q3 2024 | 273 | 60M | 100.0% | 49 / 85 | 93 / 20 | 14M | 2M |
| Q2 2024 | 245 | 59M | 100.0% | 32 / 86 | 81 / 34 | 7M | 6M |
| Q1 2024 | 251 | 58M | 100.0% | 35 / 68 | 97 / 29 | 4M | 4M |
| Q4 2023 | 246 | 58M | 99.8% | 32 / 85 | 89 / 21 | 5M | 3M |
| Q3 2023 | 238 | 57M | 98.0% | 22 / 85 | 95 / 31 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of SUPN | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3,497,167 | 6.02% | $162.65M | 0.15% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,750,148 | 3.01% | $81.40M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,459,998 | 2.51% | $67.90M | 0.08% | Jun 30, 2026 |
| Nomura Small Cap Core Fund | 1,428,904 | 2.46% | $65.99M | 1.20% | May 29, 2026 |
| Vanguard Small-Cap Index Fund | 1,263,284 | 2.17% | $58.76M | 0.03% | Jun 30, 2026 |
| Vanguard Explorer Fund | 870,341 | 1.50% | $38.84M | 0.18% | Jul 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 801,027 | 1.38% | $37.26M | 0.05% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 666,411 | 1.15% | $30.99M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 613,480 | 1.06% | $27.38M | 0.08% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF | 533,950 | 0.92% | $24.83M | 0.15% | Jun 30, 2026 |
| Loomis Sayles Small Cap Growth Fund | 497,170 | 0.86% | $23.12M | 1.02% | Jun 30, 2026 |
| iShares Russell 2000 Value ETF | 482,594 | 0.83% | $22.45M | 0.15% | Jun 30, 2026 |
| U.S. Targeted Value Portfolio | 378,733 | 0.65% | $16.90M | 0.10% | Jul 31, 2026 |
| Vanguard Tax-Managed Small-Cap Fund | 375,471 | 0.65% | $17.46M | 0.15% | Jun 30, 2026 |
| iShares S&P Small-Cap 600 Growth ETF | 359,445 | 0.62% | $16.72M | 0.20% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jack A. Khattar | President, CEO, Director | 2,216,451 | 3.81% | Aug 14, 2026 |
| Jonathan Rubin | SVP, Chief Medical Officer | 14,342 | 0.02% | Aug 14, 2026 |
| Padmanabh P. Bhatt | Sr. VP of IP, CSO | 19,795 | 0.03% | Aug 14, 2026 |
| Frank Mottola | SVP, Chief Tech. Ops. Officer | 19,544 | 0.03% | Aug 14, 2026 |
| Timothy C. Dec | Senior Vice-President & CFO | 9,129 | 0.02% | Aug 14, 2026 |
| William Todd Horich | SVP, Commercial Operations | 4,832 | 0.01% | Mar 10, 2026 |
| Frederick M. Hudson | Director | 60,413 | 0.10% | Mar 16, 2026 |
| Georges Gemayel | Director | 36,064 | 0.06% | Mar 9, 2026 |
| Carrolee Barlow | Director | 27,045 | 0.05% | Feb 25, 2026 |
| Charles W. Newhall Iii | Director | 6,365,369 | 10.95% | Feb 25, 2026 |
| Bethany Sensenig | Director | 4,475 | 0.01% | Feb 23, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Aug 12, 2026 | Option exercise | +2,500 | – | – | 19,795 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Aug 12, 2026 | Tax withholding | −1,158 | $46.57 | $53.93K | 18,637 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Aug 12, 2026 | Tax withholding | −797 | $46.57 | $37.12K | 19,544 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Aug 12, 2026 | Option exercise | +1,650 | – | – | 20,341 |
| Timothy C. Dec Senior Vice-President & CFO | Aug 12, 2026 | Tax withholding | −604 | $46.57 | $28.13K | 9,129 |
| Timothy C. Dec Senior Vice-President & CFO | Aug 12, 2026 | Option exercise | +1,250 | – | – | 9,733 |
| Jack A. Khattar President, CEO, Director | Aug 12, 2026 | Tax withholding | −12,642 | $46.57 | $588.74K | 1,258,351 |
| Jack A. Khattar President, CEO, Director | Aug 12, 2026 | Option exercise | +29,849 | – | – | 1,270,993 |
| Jonathan Rubin SVP, Chief Medical Officer | Aug 12, 2026 | Option exercise | +750 | – | – | 14,342 |
| Jonathan Rubin SVP, Chief Medical Officer | Aug 12, 2026 | Tax withholding | −363 | $46.57 | $16.90K | 13,979 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 18, 2026 | Sale(10b5-1 plan) | −6,838 | $49.55 | $338.82K | 17,456 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 18, 2026 | Option exercise | +7,250 | $39.40 | $285.65K | 24,294 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 18, 2026 | Sale(10b5-1 plan) | −412 | $50.48 | $20.80K | 17,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 17, 2026 | Sale(10b5-1 plan) | −22,290 | $50.73 | $1.13M | 17,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 17, 2026 | Sale(10b5-1 plan) | −27,710 | $49.95 | $1.38M | 39,334 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 17, 2026 | Option exercise | +15,000 | $38.60 | $579.00K | 67,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 17, 2026 | Option exercise | +12,250 | $36.75 | $450.19K | 52,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 17, 2026 | Option exercise | +22,750 | $39.40 | $896.35K | 39,794 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Sale(10b5-1 plan) | −15,886 | $50.49 | $802.08K | 17,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Sale(10b5-1 plan) | −34,114 | $50.18 | $1.71M | 32,930 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Option exercise | +5,000 | $27.94 | $139.70K | 67,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Option exercise | +18,000 | $32.20 | $579.60K | 62,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Option exercise | +4,250 | $29.61 | $125.84K | 44,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Mar 16, 2026 | Option exercise | +22,750 | $36.75 | $836.06K | 39,794 |
| Jack A. Khattar President, CEO, Director | Mar 13, 2026 | Sale(10b5-1 plan) | −24,138 | $50.09 | $1.21M | 968,962 |
| Jack A. Khattar President, CEO, Director | Mar 13, 2026 | Other | +12,500 | – | – | 1,241,144 |
| Jack A. Khattar President, CEO, Director | Mar 13, 2026 | Other | −12,500 | – | – | 993,100 |
| Jack A. Khattar President, CEO, Director | Mar 13, 2026 | Sale(10b5-1 plan) | −10,742 | $51.00 | $547.84K | 958,220 |
| Jack A. Khattar President, CEO, Director | Mar 13, 2026 | Sale(10b5-1 plan) | −120 | $51.75 | $6.21K | 958,100 |
| Frederick M. Hudson Director | Mar 12, 2026 | Sale | −5,369 | $50.61 | $271.73K | 60,413 |
| William Todd Horich SVP, Commercial Operations | Mar 10, 2026 | Sale | −4,439 | $55.00 | $244.15K | 0 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Mar 9, 2026 | Sale | −1,623 | $53.65 | $87.07K | 18,440 |
| William Todd Horich SVP, Commercial Operations | Mar 9, 2026 | Sale | −4,438 | $54.00 | $239.65K | 4,439 |
| Timothy C. Dec Senior Vice-President & CFO | Mar 6, 2026 | Option exercise | +3,000 | – | – | 8,115 |
| Timothy C. Dec Senior Vice-President & CFO | Mar 6, 2026 | Tax withholding | −1,433 | $54.73 | $78.43K | 6,682 |
| Timothy C. Dec Senior Vice-President & CFO | Mar 6, 2026 | Option exercise | +3,000 | – | – | 9,682 |
| Timothy C. Dec Senior Vice-President & CFO | Mar 6, 2026 | Tax withholding | −1,450 | $54.73 | $79.36K | 8,232 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Mar 6, 2026 | Option exercise | +3,750 | – | – | 21,856 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Mar 6, 2026 | Tax withholding | −1,793 | $54.73 | $98.13K | 20,063 |
| Jack A. Khattar President, CEO, Director | Mar 6, 2026 | Tax withholding | −16,574 | $54.73 | $907.10K | 1,228,644 |
| Jack A. Khattar President, CEO, Director | Mar 6, 2026 | Option exercise | +38,640 | – | – | 1,245,218 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Option exercise | +2,625 | – | – | 7,457 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Tax withholding | −1,216 | $54.73 | $66.55K | 6,241 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Option exercise | +3,750 | – | – | 9,991 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Tax withholding | −1,718 | $54.73 | $94.03K | 8,273 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Option exercise | +1,125 | – | – | 9,398 |
| William Todd Horich SVP, Commercial Operations | Mar 6, 2026 | Tax withholding | −521 | $54.73 | $28.51K | 8,877 |
| Georges Gemayel Director | Mar 6, 2026 | Option exercise | +7,905 | $25.30 | $200.00K | 36,064 |
| Georges Gemayel Director | Mar 6, 2026 | Sale | −8,787 | $53.00 | $465.71K | 27,277 |
| Georges Gemayel Director | Mar 5, 2026 | Sale | −10,000 | $53.71 | $537.10K | 28,159 |
| Jonathan Rubin SVP, Chief Medical Officer | Feb 25, 2026 | Tax withholding | −675 | $50.69 | $34.22K | 13,341 |
| Jonathan Rubin SVP, Chief Medical Officer | Feb 25, 2026 | Award | +1,250 | – | – | 14,016 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Feb 25, 2026 | Award | +1,875 | – | – | 19,083 |
| Frank Mottola SVP, Chief Tech. Ops. Officer | Feb 25, 2026 | Tax withholding | −977 | $50.69 | $49.52K | 18,106 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Feb 25, 2026 | Tax withholding | −650 | $50.69 | $32.95K | 17,044 |
| Padmanabh P. Bhatt Sr. VP of IP, CSO | Feb 25, 2026 | Award | +1,250 | – | – | 17,694 |
| Timothy C. Dec Senior Vice-President & CFO | Feb 25, 2026 | Tax withholding | −1,279 | $50.69 | $64.83K | 5,115 |
| Timothy C. Dec Senior Vice-President & CFO | Feb 25, 2026 | Award | +2,500 | – | – | 6,394 |
| Frederick M. Hudson Director | Feb 24, 2026 | Award | +4,475 | – | – | 65,782 |
| Timothy C. Dec Senior Vice-President & CFO | Feb 24, 2026 | Tax withholding | −242 | $50.86 | $12.31K | 2,418 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| P. Bhatt Padmanabh Officer | Mar 17, 2026 | 57,250 | $2.87M | Mar 17, 2026 | Exercise of Stock Options |
| P. Bhatt Padmanabh Officer | Mar 16, 2026 | 50,000 | $2.50M | Mar 16, 2026 | Exercise of Stock Options |
| Kbt Trust U/A Dtd 12/30/2010 The Director, Officer | Mar 13, 2026 | 35,000 | $1.77M | Mar 13, 2026 | Founders Shares |
| M. Hudson Frederick Director | Mar 12, 2026 | 5,369 | $271.75K | Mar 12, 2026 | Restricted stock vesting under a registered plan |
| Todd Horich William Officer | Mar 10, 2026 | 4,439 | $244.15K | Mar 10, 2026 | Restricted stock vesting under a registered plan |
| Todd Horich William Officer | Mar 9, 2026 | 4,438 | $239.65K | Mar 9, 2026 | Restricted stock vesting under a registered plan |
| Mottola Frank Officer | Mar 9, 2026 | 1,623 | $87.07K | Mar 9, 2026 | Restricted stock vesting under a registered plan |
| Gemayel Georges Director | Mar 6, 2026 | 8,787 | $465.77K | Mar 6, 2026 | Exercise of options under a registered plan |
| Gemayel Georges Director | Mar 5, 2026 | 10,000 | $537.12K | Mar 5, 2026 | Previously Exercised Options |
| Sensenig Bethany Director | Feb 19, 2026 | 4,475 | $224.65K | Feb 19, 2026 | Restricted Stock Units |
| Mottola Frank Officer | Dec 19, 2025 | 20,000 | $985.60K | Dec 19, 2025 | Exercise of Stock Options |
| Newhall Charles Director | Oct 9, 2025 | 25,000 | $1.20M | Oct 9, 2025 | In-Kind Distribution |
| A. Khattar Jack Director, Officer | Oct 9, 2025 | 59,900 | $2.88M | Oct 9, 2025 | Exercise of Stock Options |
| A. Khattar Jack Director, Officer | Oct 2, 2025 | 1,904 | $91.47K | Oct 2, 2025 | Exercise of Stock Options |
| A. Khattar Jack Director, Officer | Oct 1, 2025 | 40,173 | $1.92M | Oct 1, 2025 | Exercise of Stock Options |